Loss of cytoplasmic CDK1 predicts poor survival in human lung cancer and confers chemotherapeutic resistance.

The dismal lethality of lung cancer is due to late stage at diagnosis and inherent therapeutic resistance. The incorporation of targeted therapies has modestly improved clinical outcomes, but the identification of new targets could further improve clinical outcomes by guiding stratification of poor-...

Full beskrivning

Sparad:
Bibliografiska uppgifter
Huvudupphovsmän: Chunyu Zhang, Abdel G Elkahloun, Matthew Robertson, Joell J Gills, Junji Tsurutani, Joanna H Shih, Junya Fukuoka, M Christine Hollander, Curtis C Harris, William D Travis, Jin Jen, Phillip A Dennis
Materialtyp: Artigo
Språk:Inglês
Publicerad: Public Library of Science (PLoS) 2011-01-01
Serie:PLoS ONE
Länkar:http://europepmc.org/articles/PMC3161069?pdf=render
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk